Advancing Precision Oncology: Trends and Levers Driving Biomarker Testing Into Practice [On Demand]

Webinar Recorded August 27, 2026                           Pricing: Free for Members and Non-Members

Please note that this session is not accredited for continuing pharmacy education credit.

Program Description

Biomarker testing is central to delivering precision oncology, but adoption still varies by tumor type and care setting. Drawing on IQVIA's new Advancing Precision Oncology report, we will walk through current testing trends and the levers — clinical evidence, guideline inclusion, and institutional champions — that move biomarkers from evidence into everyday practice, along with the barriers still holding adoption back. We'll close with a quick pipeline update on what's next in oncology therapeutics.

Course summary

Course opens: 
08/27/2026
Course expires: 
08/31/2027
Cost:
$0.00

Speakers:

Simone Ndujiuba, PharmD, BCOP
Hematology/Oncology Expert

Vibhu Tewary
Director, IQVIA Institute for Human Data Science

Price

Cost:
$0.00
Please login or register to take this course.

By registering for this event, you agree not to use any form of artificial intelligence (AI) technology to record, transcribe, or reproduce educational sessions, presentations, or discussions in any format.

Click here for more information on AMCP membership or email memberservices@amcp.org.